| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |